Amgen Inc. on Tuesday reported first-quarter net income of $1.62 billion.
On a per-share basis, the Thousand Oaks-based company said it had net income of $2.11. Earnings, adjusted for costs related to mergers and acquisitions, were $2.48 per share.
The results exceeded Wall Street expectations. The average estimate of analysts surveyed by Zacks Investment Research was for earnings of $2.07 per share.
The world's largest biotech drugmaker posted revenue of $5.03 billion in the period, also beating Street forecasts. Snalysts surveyed by Zacks expected $4.92 billion.
Amgen expects full-year earnings in the range of $9.35 to $9.65 per share, with revenue in the range of $20.9 billion to $21.3 billion.